Nasdaq halts trading for two Houston biotech firms

Financial regulators have clamped down on companies issuing statements about testing and potential treatments for Covid-19.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.